Evaluation of serum argininosuccinate lyase (ASAL) concentrations as an index to parenchymal liver disease.
D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D001120:Arginine; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D001706:Biopsy; D001798:Blood Proteins / Q000032:analysis; D002784:Cholesterol / Q000097:blood; D002908:Chronic Disease; D004796:Clinical Enzyme Tests; D003402:Creatine Kinase / Q000097:blood; D005650:Fumarates; D006505:Hepatitis / Q000201:enzymology; D006506:Hepatitis A / Q000201:enzymology; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008099:Liver / Q000473:pathology; D008107:Liver Diseases / Q000097:blood / Q000175:diagnosis / Q000201:enzymology*; D008113:Liver Neoplasms / Q000201:enzymology; D008190:Lyases / Q000097:blood*; D008722:Methods; D009362:Neoplasm Metastasis; D013386:Succinates
D001798:Blood Proteins; D005650:Fumarates; D013386:Succinates; D001120:Arginine; D002784:Cholesterol; D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D003402:Creatine Kinase; D000469:Alkaline Phosphatase; D008190:Lyases; D001663:Bilirubin